We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Artel Expands Portfolio with STRATEC Partnership for Automation Technology

By LabMedica International staff writers
Posted on 16 Feb 2015
Artel (Westbrook, Maine, USA), a leader in laboratory liquid handling measurement systems, and STRATEC Biomedical AG (Birkenfeld, Germany), a leader in automated systems for clinical diagnostics and biotechnology, have entered into a strategic partnership for STRATEC’s innovative “Tholos” technology, which measures liquid and solid contents of 96- and 384-well microplates. More...


Artel will be the exclusive marketer for the “Tholos” technology, under the name Artel “SDS” - Sample Detection System, in the United States, Canada, Germany, Australia, and Switzerland. The companies will also work together on future technology enhancements for the product.

Designed to improve in-line process efficiency and quality assurance in compound management and storage, SDS can also assess the delivery accuracy and precision of automated liquid handlers. By sealing and pressurizing individual microplate wells, SDS measures their contents, down to 1% of the potential volume, regardless of the shape, material, or color of the well or tube. It is an ideal complement to Artel’s “MVS” - Multichannel Verification System, which verifies aqueous-based volume transfers.

“This system closes a gap in automation processes,” said Marcus Wolfinger, chairman, Board of Management, STRATEC, “We are very proud to have gained Artel, the global market leader in liquid handling quality assurance, as a partner.”

“Our customers will benefit from this powerful technology, which further enhances their ability to ensure high-quality results,” said Kirby Pilcher, president, Artel, “The partnership with STRATEC, a worldwide leader in their field, has resulted in a perfect addition to Artel’s portfolio of liquid handling quality assurance products and services.”

Related Links:

Artel
Stratec Biomedical



Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Homocysteine Quality Control
Liquichek Homocysteine Control
Gold Member
Hybrid Pipette
SWITCH
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Whole-genome sequencing enables broader detection of DNA repair defects to guide PARP inhibitor cancer therapy (Photo courtesy of Illumina)

Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment

Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more

Pathology

view channel
Image: AI models combined with DOCI can classify thyroid cancer subtypes (Photo courtesy of T. Vasse et al., doi 10.1117/1.BIOS.3.1.015001)

AI-Powered Label-Free Optical Imaging Accurately Identifies Thyroid Cancer During Surgery

Thyroid cancer is the most common endocrine cancer, and its rising detection rates have increased the number of patients undergoing surgery. During tumor removal, surgeons often face uncertainty in distinguishing... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.